These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 3392892)
21. 24-hour serum concentration profile of cortisol in patients with Cushing's disease. Pirich K; Vierhapper H Exp Clin Endocrinol; 1988 Mar; 92(3):275-9. PubMed ID: 2855318 [TBL] [Abstract][Full Text] [Related]
22. Use of a parenteral propylene glycol-containing etomidate preparation for the long-term management of ectopic Cushing's syndrome. Krakoff J; Koch CA; Calis KA; Alexander RH; Nieman LK J Clin Endocrinol Metab; 2001 Sep; 86(9):4104-8. PubMed ID: 11549633 [TBL] [Abstract][Full Text] [Related]
23. The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cushing's syndrome. Chrousos GP; Schulte HM; Oldfield EH; Gold PW; Cutler GB; Loriaux DL N Engl J Med; 1984 Mar; 310(10):622-6. PubMed ID: 6319991 [TBL] [Abstract][Full Text] [Related]
24. Treatment of severe psychosis due to ectopic Cushing's syndrome. Bilgin YM; van der Wiel HE; Fischer HR; De Herder WW J Endocrinol Invest; 2007 Oct; 30(9):776-9. PubMed ID: 17993771 [TBL] [Abstract][Full Text] [Related]
25. A comparison of adrenal cortical function in patients with depressive illness and Cushing's disease. Schlechte JA; Sherman B; Pfohl B Horm Res; 1986; 23(1):1-8. PubMed ID: 3940937 [TBL] [Abstract][Full Text] [Related]
26. Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome. Isidori AM; Kaltsas GA; Mohammed S; Morris DG; Jenkins P; Chew SL; Monson JP; Besser GM; Grossman AB J Clin Endocrinol Metab; 2003 Nov; 88(11):5299-306. PubMed ID: 14602765 [TBL] [Abstract][Full Text] [Related]
27. Etomidate infusion in the critical care setting for suppressing the acute phase of Cushing's syndrome. Dabbagh A; Sa'adat N; Heidari Z Anesth Analg; 2009 Jan; 108(1):238-9. PubMed ID: 19095856 [TBL] [Abstract][Full Text] [Related]
28. Corticotropin releasing hormone stimulation test: diagnostic aspects in Cushing's syndrome. Boscaro M; Rampazzo A; Sonino N; Merola G; Scanarini M; Mantero F J Endocrinol Invest; 1987 Jun; 10(3):297-302. PubMed ID: 3040851 [TBL] [Abstract][Full Text] [Related]
29. Medical suppression of hypercortisolemia in Cushing's syndrome with particular consideration of etomidate. Heyn J; Geiger C; Hinske CL; Briegel J; Weis F Pituitary; 2012 Jun; 15(2):117-25. PubMed ID: 21556813 [TBL] [Abstract][Full Text] [Related]
30. Responsiveness of the hypophyseal-adrenocortical axis to corticotropin-releasing factor in pituitary-dependent Cushing's disease. Pieters GF; Hermus AR; Smals AG; Bartelink AK; Benraad TJ; Kloppenborg PW J Clin Endocrinol Metab; 1983 Sep; 57(3):513-6. PubMed ID: 6308029 [TBL] [Abstract][Full Text] [Related]
31. Medical treatment of Cushing's syndrome: adrenal-blocking drugs and ketaconazole. Feelders RA; Hofland LJ; de Herder WW Neuroendocrinology; 2010; 92 Suppl 1():111-5. PubMed ID: 20829630 [TBL] [Abstract][Full Text] [Related]
32. The relationship between cortisol production rate and serial serum cortisol estimation in patients on medical therapy for Cushing's syndrome. Trainer PJ; Eastment C; Grossman AB; Wheeler MJ; Perry L; Besser GM Clin Endocrinol (Oxf); 1993 Oct; 39(4):441-3. PubMed ID: 8287570 [TBL] [Abstract][Full Text] [Related]
33. Pneumocystis pneumonia during medicamentous treatment of Cushing's syndrome--a description of two cases. Gabalec F; Zavrelová A; Havel E; Cerman J; Radocha J; Svilias I; Cáp J Acta Medica (Hradec Kralove); 2011; 54(3):127-30. PubMed ID: 22250484 [TBL] [Abstract][Full Text] [Related]
34. A combined test using desmopressin and corticotropin-releasing hormone in the differential diagnosis of Cushing's syndrome. Newell-Price J; Perry L; Medbak S; Monson J; Savage M; Besser M; Grossman A J Clin Endocrinol Metab; 1997 Jan; 82(1):176-81. PubMed ID: 8989255 [TBL] [Abstract][Full Text] [Related]
35. Suppressibility of plasma adrenocorticotropin by hydrocortisone: potential usefulness in the diagnosis of Cushing's disease. Streeten DH; Anderson GH; Brennan S; Jones C J Clin Endocrinol Metab; 1998 Apr; 83(4):1114-20. PubMed ID: 9543127 [TBL] [Abstract][Full Text] [Related]
36. Circadian pattern of serum androgens in women with Cushing's syndrome. Kreze A; Mikulecky M; Putz Z; Moravcik M Acta Med Hung; 1992-1993; 49(3-4):171-8. PubMed ID: 1345454 [TBL] [Abstract][Full Text] [Related]
37. Serum cortisol concentrations during low dose dexamethasone suppression test to screen for Cushing's syndrome. Kennedy L; Atkinson AB; Johnston H; Sheridan B; Hadden DR Br Med J (Clin Res Ed); 1984 Nov; 289(6453):1188-91. PubMed ID: 6437479 [TBL] [Abstract][Full Text] [Related]
38. Human corticotropin releasing hormone test performance in the differential diagnosis between Cushing's disease and pseudo-Cushing state is enhanced by combined ACTH and cortisol analysis. Arnaldi G; Tirabassi G; Papa R; Furlani G; Trementino L; Cardinaletti M; Faloia E; Boscaro M Eur J Endocrinol; 2009 Jun; 160(6):891-8. PubMed ID: 19321661 [TBL] [Abstract][Full Text] [Related]
39. Plasma corticotropin and cortisol responses to ovine corticotropin-releasing hormone (CRH), arginine vasopressin (AVP), CRH plus AVP, and CRH plus metyrapone in patients with Cushing's disease. Dickstein G; DeBold CR; Gaitan D; DeCherney GS; Jackson RV; Sheldon WR; Nicholson WE; Orth DN J Clin Endocrinol Metab; 1996 Aug; 81(8):2934-41. PubMed ID: 8768855 [TBL] [Abstract][Full Text] [Related]